MRM Proteomics provides advanced proteomics services to the pharmaceutical, biotechnology and diagnostics industries in key areas such as biomarker discovery/validation, clinical studies, diagnostics and toxicology.

As a leader in targeted proteomics approaches, we specialize in the highly multiplexed quantitation of >100 protein biomarkers in complex biological samples such as blood, cerebrospinal fluid, urine and other fluids/tissues.

Our workflows use Multiple Reaction Monitoring-Mass Spectrometry (MRM-MS) with isotopically-labeled internal standards to achieve unparalleled specificity and sensitivity. This approach uses minimal sample volumes (20 ul) and  does not require depletion of high-abundance proteins.  

MRM Proteomics Inc. was established in 2010 as a spin-out company to commercialize the cutting-edge proteomics technologies, tools and know-how developed at the University of Victoria-Genome BC Proteomics Centre.